中文版
  • Home
  • About Us
    • Company Profile
    • Culture
    • Join Us
    • Contact Us
  • Products
    • Marketed Vaccine
    • R&D Vaccine
  • R&D
    • R&D Overview
    • Research achievements
  • International
    • International project
    • Overseas Market
    • International Certificate
  • News
    • Company News
    • Industry News
    • Latest Announcement
  • Home
  • About Us
    About Us

    Company Profile

    • About Us
    • Enterprise Honor
    • Development History

    Culture

    • Cultural Concept
    • Staff Presence
    • Social Responsibility

    Join Us

    • Join Us
    • Talent Concept
    • Well-paid Job

    Contact Us

  • Products
    Products service

    Marketed Vaccine

    • SARS-COV-2 VACCINE(VERO CELL), INACTIVATED
    • Hib Conjugate Vaccine, Freeze-dried
    • 13-Valent Pneumococcal Conjugate Vaccine
    • Recombinant Hepatitis B Vaccine
    • 23-Valent Pneumococcal Polysaccharide Vaccine
    • Diphtheria Tetanus Acellular Pertussis and Haemophilus Influenzae Type b Combined Vaccine
    • Haemophilus Influenzae Type b Conjugate Vaccine
    • Measles and Rubella Combined Vaccine ,Live

    R&D Vaccine

    • Rabies vaccine (human diploid cell) for human use, Freeze-dried
    • Inactivated Poliomyelitis Vaccine, Sabin Strains
    • Live attenuated Varicella Vaccine, Freeze-dried
  • Service
    Service

    Vaccine Science

    Information Disclosure

  • R&D
    R&D

    R&D Overview

    Scientific Payoffs

    R&D Project

  • International
    International

    Cooperative Project

    International Exchange

    International Certificate

    • GMP Certificate
    • Products Certificate

    Overseas Market

  • Investor Relations
    Investor Relations

    Corporate Governance

    • Company Announcements
    • Shareholder Returns

    Stock quotation

    • Investor Online
    • Investors Contact
  • News
    News

    Company News

    Industry News

    Latest Announcement

中文版
Home > R&D
R&D
R&D Overview Achievements Reasearch Project

 

Products

R&D

Service

International

News

  • Marketed Vaccine
  • R&D Vaccine
  • R&D Overview
  • Scientific Payoffs
  • R&D Project
  • Vaccine Science
  • Information Disclosure
  • Cooperative Project
  • International Exchange
  • International Certificate
  • Overseas Market
  • Company News
  • Latest Announcement
  • Industry News

Wechat BKT

Wechat BKT

Shenzhen Kangtai Biological Products Co., Ltd.

  • Company Address Headquarter Address:101 kangtai Group Building, No.222 kefa Road,Nanshan District,Shenzhen
  • Company Address GuangMing Base:No.18, Shutianpu Road, GuangMing District, ShenZhen
  • Company Address XiLi Base:No.128 Songwang Road, Nanshan District, ShenZhen
  • Service Online Tel:+86 755-26988658 Fax:+86 755-26988600
  • E-Mail E-Mail: [email protected]
Subsidiary Corporation:
  • Beijing Minhai Biological Technology Co., Ltd.
  • Copyright © 1992-2021 BiokangtaiHot Line: 400-880-6992粤ICP备06026377
    Home Products Tel:
    • 0755-26988688
    • Wechat BKT